338 related articles for article (PubMed ID: 18535804)
1. CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.
Peters N; Wieners G; Pech M; Hengst S; Rühl R; Streitparth F; Lopez Hänninen E; Felix R; Wust P; Ricke J
Strahlenther Onkol; 2008 Jun; 184(6):296-301. PubMed ID: 18535804
[TBL] [Abstract][Full Text] [Related]
2. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer.
Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ
Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997
[TBL] [Abstract][Full Text] [Related]
3. [CT-guided interstitial brachytherapy of lung malignancies. Technique and first results].
Ricke J; Wust P; Hengst S; Wieners G; Pech M; Herzog H; Felix R
Radiologe; 2004 Jul; 44(7):684-6. PubMed ID: 15221154
[TBL] [Abstract][Full Text] [Related]
4. CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a novel technique.
Ricke J; Wust P; Wieners G; Hengst S; Pech M; Lopez Hänninen E; Felix R
Chest; 2005 Jun; 127(6):2237-42. PubMed ID: 15947343
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
6. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
7. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
8. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy for small-sized peripherally located lung cancer.
Imamura F; Ueno K; Kusunoki Y; Uchida J; Yoshimura M; Koizumi M; Yamasaki H; Nishiyama K
Strahlenther Onkol; 2006 Dec; 182(12):703-7. PubMed ID: 17149576
[TBL] [Abstract][Full Text] [Related]
10. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
Davidson MT; Yuen J; D'Souza DP; Batchelar DL
Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
[TBL] [Abstract][Full Text] [Related]
11. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
[TBL] [Abstract][Full Text] [Related]
12. Helical tomotherapy. Experiences of the first 150 patients in Heidelberg.
Sterzing F; Schubert K; Sroka-Perez G; Kalz J; Debus J; Herfarth K
Strahlenther Onkol; 2008 Jan; 184(1):8-14. PubMed ID: 18188517
[TBL] [Abstract][Full Text] [Related]
13. CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis.
Pech M; Wieners G; Kryza R; Dudeck O; Seidensticker M; Mohnike K; Redlich U; Rühl R; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 Jun; 184(6):302-6. PubMed ID: 18535805
[TBL] [Abstract][Full Text] [Related]
14. [CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases].
Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Lopez Hänninen E; Felix R
Strahlenther Onkol; 2004 May; 180(5):274-80. PubMed ID: 15127157
[TBL] [Abstract][Full Text] [Related]
15. Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Xiang L; Zhang JW; Lin S; Luo HQ; Wen QL; He LJ; Shang CL; Ren PR; Yang HR; Pang HW; Yang B; He HL; Chen Y; Wu JB
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1027-1034. PubMed ID: 26194678
[TBL] [Abstract][Full Text] [Related]
16. Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy.
Kolotas C; Tselis N; Sommerlad M; Röddiger S; Schnabel T; Baltas D; Kalogera-Fountzila A; Fountzilas G; Zamboglou N
Strahlenther Onkol; 2007 Feb; 183(2):69-75. PubMed ID: 17294110
[TBL] [Abstract][Full Text] [Related]
17. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
Agrawal PP; Singhal SS; Neema JP; Suryanarayan UK; Vyas RK; Rathi AK; Bahadur AK
Gynecol Oncol; 2005 Oct; 99(1):169-75. PubMed ID: 16081150
[TBL] [Abstract][Full Text] [Related]
18. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
19. CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC).
Martínez-Monge R; Pagola M; Vivas I; López-Picazo JM
Lung Cancer; 2008 Aug; 61(2):209-13. PubMed ID: 18243409
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM
Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
